HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction.

Abstract
Dupuytren's disease (DD) is a common fibrotic condition of the palmar fascia, leading to deposition of collagen-rich cords and progressive flexion of the fingers. The molecular mechanisms underlying the disease are poorly understood. We have previously shown altered expression of extracellular matrix-degrading proteases (matrix metalloproteases, MMPs, and 'a disintegrin and metalloprotease domain with thrombospondin motifs', ADAMTS, proteases) in palmar fascia from DD patients compared to control and shown that the expression of a sub-set of these genes correlates with post-operative outcome. In the current study we used an in vitro model of collagen contraction to identify the specific proteases which mediate this effect. We measured the expression of all MMPs, ADAMTSs and their inhibitors in fibroblasts derived from the palmar fascia of DD patients, both in monolayer culture and in the fibroblast-populated collagen lattice (FPCL) model of cell-mediated contraction. Key proteases, previously identified in our tissue studies, were expressed in vitro and regulated by tension in the FPCL, including MMP1, 2, 3, 13 and 14. Knockdown of MMP2 and MMP14 (but not MMP1, 3 and 13) inhibited cell-mediated contraction, and knockdown of MMP14 inhibited proMMP-2 activation. Interestingly, whilst collagen is degraded during the FPCL assay, this is not altered upon knockdown of any of the proteases examined. We conclude that MMP-14 (via its ability to activate proMMP-2) and MMP-2 are key proteases in collagen contraction mediated by fibroblasts in DD patients. These proteases may be drug targets or act as biomarkers for disease progression.
AuthorsJanine M Wilkinson, Rose K Davidson, Tracey E Swingler, Eleanor R Jones, Anthony N Corps, Phillip Johnston, Graham P Riley, Adrian J Chojnowski, Ian M Clark
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1822 Issue 6 Pg. 897-905 (Jun 2012) ISSN: 0006-3002 [Print] Netherlands
PMID22342364 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 Elsevier B.V. All rights reserved.
Chemical References
  • RNA, Small Interfering
  • Matrix Metalloproteinase 13
  • Matrix Metalloproteinase 3
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 1
  • Matrix Metalloproteinase 14
Topics
  • Cells, Cultured
  • Dupuytren Contracture (metabolism, pathology)
  • Fascia (metabolism)
  • Humans
  • Matrix Metalloproteinase 1 (genetics, metabolism)
  • Matrix Metalloproteinase 13 (genetics, metabolism)
  • Matrix Metalloproteinase 14 (genetics, metabolism)
  • Matrix Metalloproteinase 2 (genetics, metabolism)
  • Matrix Metalloproteinase 3 (genetics, metabolism)
  • Palmar Plate (pathology)
  • RNA Interference
  • RNA, Small Interfering

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: